BHS DIAGNOSTICS LIMITED
Company number 12582387 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
BHS DIAGNOSTICS LIMITED - Analysis Report
Company Number: 12582387
Analysis Date: 2025-07-20 13:48 UTC
Financial Health Assessment of BHS DIAGNOSTICS LIMITED (as of 30 April 2024)
1. Financial Health Score: B+
Explanation:
BHS Diagnostics Limited demonstrates a solid financial footing with positive net current assets, growing shareholders’ funds, and consistent profitability. The business exhibits a "healthy cash flow" symptom with strong liquidity and low short-term liabilities. However, the company is very small scale (single director, single employee) and has modest capital base, limiting resilience to shocks. Overall, the score reflects a financially sound but still developing SME with room to strengthen working capital and diversify revenue streams.
2. Key Vital Signs:
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Current Assets | £40,408 | Adequate liquid assets available |
| Cash | £40,408 | Entirely cash-based current assets; excellent liquidity |
| Debtors | £0 | No outstanding receivables, reducing credit risk |
| Current Liabilities | £4,315 | Low short-term debts; manageable obligations |
| Net Current Assets | £36,093 | Strong working capital; "healthy cash flow" |
| Shareholders’ Funds | £36,093 | Solid equity base with gradual growth |
| Profit for the Year | £5,792 | The company is generating profits consistently |
| Dividends Paid | £1,000 | Moderate dividend payout, preserving capital |
| Employee Count | 1 | Very small operation; high dependency on director |
| Share Capital | £10 | Minimal capital invested; risks linked to scale |
3. Diagnosis:
Liquidity & Working Capital: The company shows a strong liquidity position with all current assets held as cash and very low current liabilities. This indicates excellent capacity to meet short-term obligations without financial strain—a key sign of financial health. The absence of debtors suggests prompt collection or cash-based business, reducing risks of bad debts.
Profitability & Growth: Profit reserves have increased steadily from £14,797 in 2021 to £36,083 in 2024, reflecting consistent profitability and retained earnings. The director’s decision to retain the majority of profits within the business (only modest dividends paid) strengthens financial stability.
Capital Structure: The company’s share capital is nominal (£10), typical for small private limited companies. The shareholder equity growth is driven by retained profits rather than fresh capital injections. While this is positive, it also means the company’s financial "immune system" depends heavily on operational cash flows.
Size & Operational Risk: As a single-director, single-employee entity, the business is highly dependent on the director’s expertise and continuity. This creates a "single point of failure" risk. The company’s small scale limits diversification of revenue and operational flexibility.
Other Considerations: The company is active and compliant with filing duties, indicating good governance. The sector (specialists’ medical practice) is generally stable. No long-term liabilities or borrowings are recorded, keeping financial risk low.
4. Recommendations:
Build Debtor Base Carefully: While the current absence of debtors minimizes credit risk, cautious expansion of client credit terms could support growth. Establishing a controlled debtor ledger with clear credit policies would help manage cash flow and customer relationships.
Increase Capital Buffer: Consider increasing share capital or retaining more profits to build a stronger equity base. This will provide a larger financial cushion against unexpected downturns or investment needs.
Diversify Operational Capacity: Explore hiring or partnering to reduce dependency on the sole director and build operational resilience. This could include administrative support or additional medical specialists.
Monitor Cash Utilization: With all current assets in cash, ensure funds are optimally used—whether for growth investments, technology upgrades, or marketing—to avoid opportunity cost of idle cash.
Plan for Growth: Develop a strategic plan to grow client base and service offerings, balancing profitability with manageable risk. Track key performance indicators regularly to detect early signs of financial "symptoms" such as declining margins or rising liabilities.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.